BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/28/2026 9:23:39 AM | Browse: 63 | Download: 205
 |
Received |
|
2025-09-01 09:46 |
|
Peer-Review Started |
|
2025-09-01 09:48 |
|
First Decision by Editorial Office Director |
|
2025-10-18 02:31 |
|
Return for Revision |
|
2025-10-18 02:31 |
|
Revised |
|
2025-10-31 21:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-22 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-22 07:49 |
|
Articles in Press |
|
2025-12-22 07:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-20 00:31 |
|
Publish the Manuscript Online |
|
2026-01-28 09:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kyle R Stephens, Megan Wilson, Manting Xu, Jeremy T Gaskins, Gina Genova and Robert C G Martin II |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Robert C G Martin II, MD, PhD, Division of Surgical Oncology, Hiram C Polk Jr, MD, Department of Surgery, University of Louisville, 315 E Broadway, Louisville, KY 40202, United States. robert.martin@louisville.edu |
| Key Words |
Hepatocellular carcinoma; Biomarker; Serum; Recurrence; Mac-2 binding protein glycosylation isomer |
| Core Tip |
Predicting tumor recurrence following curative treatment for hepatocellular carcinoma (HCC) remains a challenging task. Numerous novel biomarkers have been investigated for their ability to predict disease prognosis, as there is a clear need for noninvasive serum assays that can reliably assess the risk for post-treatment recurrence. Mac-2 binding protein glycosylation isomer (M2BPGi) has emerged as a serum biomarker for liver fibrosis, an important component of HCC pathogenesis. Our meta-analysis demonstrates M2BPGi’s utility as a pre-operative predictor of HCC recurrence. |
| Publish Date |
2026-01-28 09:23 |
| Citation |
Stephens KR, Wilson M, Xu M, Gaskins JT, Genova G, Martin II RCG. Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma. World J Gastroenterol 2026; 32(5): 113693 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i5/113693.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i5.113693 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
